Published on 10/26/2022 in the Prospect News Investment Grade Daily.
New Issue: Elevance Health sells $1.8 billion of senior notes in three tranches
By Wendy Van Sickle
Columbus, Ohio, Oct. 26 – Elevance Health, Inc. priced $1.8 billion of fixed-rate senior notes (Baa2/A/BBB) in three tranches on Wednesday, according to an FWP filed with the Securities and Exchange Commission.
The company sold $400 million of 5.35% three-year notes at a spread of Treasuries plus 95 basis points. These notes priced at 99.974 to yield 5.361%.
Elevance additionally priced $650 million of 5.5% 10-year notes with a 155 bps spread over Treasuries. These notes priced at 99.384 to yield 5.582%.
Also, Elevance sold $750 million of 6.1% 30-year notes at a spread of 190 bps over Treasuries. These notes priced at 99.991 to yield 6.101%.
Each tranche will feature a make-whole call followed by a par call.
The notes also have change-of-control puts at 101.
BofA Securities, Inc., Deutsche Bank Securities Inc., Credit Suisse Securities (USA) LLC, Morgan Stanley & Co. LLC, PNC Capital Markets LLC and Wells Fargo Securities, LLC are the joint bookrunning managers for the offering.
Proceeds will be used for working capital and for general corporate purposes, including funding of acquisitions, repayment of short-term and long-term debt, and repurchase of common stock under the company’s share repurchase program.
Formerly known as Anthem, Inc., Indianapolis-based Elevance is a health benefits company.
Issuer: | Elevance Health, Inc.
|
Amount: | $1.8 billion
|
Issue: | Senior notes
|
Bookrunners: | BofA Securities, Inc., Deutsche Bank Securities Inc., Credit Suisse Securities (USA) LLC, Morgan Stanley & Co. LLC, PNC Capital Markets LLC and Wells Fargo Securities, LLC
|
Senior co-managers: | Barclays, Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Truist Securities, Inc. and U.S. Bancorp Investments, Inc.
|
Junior co-managers: | BNY Mellon Capital Markets, LLC. and Huntington Securities, Inc.
|
Trustee: | Bank of New York Mellon Trust Co., NA
|
Counsel to issuer: | Hogan Lovells US LLP with assistance on Indiana law from Faegre Drinker Biddle & Reath LLP
|
Counsel to underwriters: | Davis Polk & Wardwell LLP
|
Change-of-control put: | At 101
|
Pricing date: | Oct. 26
|
Settlement date: | Nov. 4
|
Ratings: | Moody’s: Baa2
|
| S&P: A
|
| Fitch: BBB
|
Distribution: | SEC registered
|
|
Notes due 2025
|
Amount: | $400 million
|
Maturity: | Oct. 15, 2025
|
Coupon: | 5.35%
|
Price: | 99.974
|
Yield: | 5.361%
|
Spread: | Treasuries plus 95 bps
|
Call feature: | Make-whole call at Treasuries plus 15 bps prior to Sept. 15, 2025, then a par call
|
Cusip: | 036752AV5
|
|
Notes due 2032
|
Amount: | $650 million
|
Maturity: | Oct. 15, 2032
|
Coupon: | 5.5%
|
Price: | 99.384
|
Yield: | 5.582%
|
Spread: | Treasuries plus 155 bps
|
Call feature: | Make-whole call at Treasuries plus 25 bps prior to July 15, 2032, then a par call
|
Cusip: | 036752AW3
|
|
Notes due 2052
|
Amount: | $750 million
|
Maturity: | Oct. 15, 2052
|
Coupon: | 6.1%
|
Price: | 99.991
|
Yield: | 6.101%
|
Spread: | Treasuries plus 190 bps
|
Call feature: | Make-whole call at Treasuries plus 30 bps prior to April 15, 2052, then a par call
|
Cusip: | 036752AX1
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.